Dulaglutide – New in the Treatment of Type 2 Diabetes

Effective Pharmacotherapy
doi 10.33978/2307-3586-2019-15-25-20-28
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medforum

Related search

Dulaglutide Slows Kidney Disease in Type 2 Diabetes

The Lancet
Medicine
2020English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply

The Lancet
Medicine
2020English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

Pharmacy Today
2014English

The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients With Type 2 Diabetes Mellitus in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Treatment of Type 2 Diabetes in Youth

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2011English

The Evolution of Type 2 Diabetes Treatment Approaches

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

New Insights Into the Pharmacological Treatment of Pediatric Patients With Type 2 Diabetes

Clinical Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy